Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,786
archived clinical trials in
Dermatology

Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic Dermatitis
A Phase 2a, Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of MEDI9929 in Adult Subjects With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated:  1/19/2018
Clinical Research Facility
mi
from
Portland, OR
Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic Dermatitis
A Phase 2a, Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of MEDI9929 in Adult Subjects With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 1/19/2018
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic Dermatitis
A Phase 2a, Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of MEDI9929 in Adult Subjects With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated:  1/19/2018
Clinical Research Facility
mi
from
Arlington Hts, IL
Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic Dermatitis
A Phase 2a, Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of MEDI9929 in Adult Subjects With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 1/19/2018
Clinical Research Facility
mi
from
Arlington Hts, IL
Click here to add this to my saved trials
Simulines Non-Inferiority Pivotal Study
Non-Inferiority Study of the Safety and Efficacy of Ultherapy® Using Standard Versus Simulines Transducers at a Reduced Energy Level for Patient Comfort
Status: Enrolling
Updated:  1/19/2018
Clinical Testing of Beverly Hills
mi
from
Beverly Hills, CA
Simulines Non-Inferiority Pivotal Study
Non-Inferiority Study of the Safety and Efficacy of Ultherapy® Using Standard Versus Simulines Transducers at a Reduced Energy Level for Patient Comfort
Status: Enrolling
Updated: 1/19/2018
Clinical Testing of Beverly Hills
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Simulines Non-Inferiority Pivotal Study
Non-Inferiority Study of the Safety and Efficacy of Ultherapy® Using Standard Versus Simulines Transducers at a Reduced Energy Level for Patient Comfort
Status: Enrolling
Updated:  1/19/2018
Roseville Facial Plastic Surgery
mi
from
Roseville, CA
Simulines Non-Inferiority Pivotal Study
Non-Inferiority Study of the Safety and Efficacy of Ultherapy® Using Standard Versus Simulines Transducers at a Reduced Energy Level for Patient Comfort
Status: Enrolling
Updated: 1/19/2018
Roseville Facial Plastic Surgery
mi
from
Roseville, CA
Click here to add this to my saved trials
Simulines Non-Inferiority Pivotal Study
Non-Inferiority Study of the Safety and Efficacy of Ultherapy® Using Standard Versus Simulines Transducers at a Reduced Energy Level for Patient Comfort
Status: Enrolling
Updated:  1/19/2018
Laser and Skin Surgery Center
mi
from
Sacramento, CA
Simulines Non-Inferiority Pivotal Study
Non-Inferiority Study of the Safety and Efficacy of Ultherapy® Using Standard Versus Simulines Transducers at a Reduced Energy Level for Patient Comfort
Status: Enrolling
Updated: 1/19/2018
Laser and Skin Surgery Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Simulines Non-Inferiority Pivotal Study
Non-Inferiority Study of the Safety and Efficacy of Ultherapy® Using Standard Versus Simulines Transducers at a Reduced Energy Level for Patient Comfort
Status: Enrolling
Updated:  1/19/2018
Dermatology Cosmetic Laser Medical Associates of La Jolla, Inc.
mi
from
San Diego, CA
Simulines Non-Inferiority Pivotal Study
Non-Inferiority Study of the Safety and Efficacy of Ultherapy® Using Standard Versus Simulines Transducers at a Reduced Energy Level for Patient Comfort
Status: Enrolling
Updated: 1/19/2018
Dermatology Cosmetic Laser Medical Associates of La Jolla, Inc.
mi
from
San Diego, CA
Click here to add this to my saved trials
Simulines Non-Inferiority Pivotal Study
Non-Inferiority Study of the Safety and Efficacy of Ultherapy® Using Standard Versus Simulines Transducers at a Reduced Energy Level for Patient Comfort
Status: Enrolling
Updated:  1/19/2018
AboutSkin Dermatology
mi
from
Greenwood Village, CO
Simulines Non-Inferiority Pivotal Study
Non-Inferiority Study of the Safety and Efficacy of Ultherapy® Using Standard Versus Simulines Transducers at a Reduced Energy Level for Patient Comfort
Status: Enrolling
Updated: 1/19/2018
AboutSkin Dermatology
mi
from
Greenwood Village, CO
Click here to add this to my saved trials
Simulines Non-Inferiority Pivotal Study
Non-Inferiority Study of the Safety and Efficacy of Ultherapy® Using Standard Versus Simulines Transducers at a Reduced Energy Level for Patient Comfort
Status: Enrolling
Updated:  1/19/2018
Maryland Laser Skin and Vein Dermatology
mi
from
Cockeysville, MD
Simulines Non-Inferiority Pivotal Study
Non-Inferiority Study of the Safety and Efficacy of Ultherapy® Using Standard Versus Simulines Transducers at a Reduced Energy Level for Patient Comfort
Status: Enrolling
Updated: 1/19/2018
Maryland Laser Skin and Vein Dermatology
mi
from
Cockeysville, MD
Click here to add this to my saved trials
Simulines Non-Inferiority Pivotal Study
Non-Inferiority Study of the Safety and Efficacy of Ultherapy® Using Standard Versus Simulines Transducers at a Reduced Energy Level for Patient Comfort
Status: Enrolling
Updated:  1/19/2018
Wilmington Dermatology Center
mi
from
Wilmington, NC
Simulines Non-Inferiority Pivotal Study
Non-Inferiority Study of the Safety and Efficacy of Ultherapy® Using Standard Versus Simulines Transducers at a Reduced Energy Level for Patient Comfort
Status: Enrolling
Updated: 1/19/2018
Wilmington Dermatology Center
mi
from
Wilmington, NC
Click here to add this to my saved trials
Simulines Non-Inferiority Pivotal Study
Non-Inferiority Study of the Safety and Efficacy of Ultherapy® Using Standard Versus Simulines Transducers at a Reduced Energy Level for Patient Comfort
Status: Enrolling
Updated:  1/19/2018
Premier Clinical Research
mi
from
Spokane, WA
Simulines Non-Inferiority Pivotal Study
Non-Inferiority Study of the Safety and Efficacy of Ultherapy® Using Standard Versus Simulines Transducers at a Reduced Energy Level for Patient Comfort
Status: Enrolling
Updated: 1/19/2018
Premier Clinical Research
mi
from
Spokane, WA
Click here to add this to my saved trials
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
A Randomized, Double-blind, Multicentric, Parallel-group, Active and Placebo Controlled, Three Arm Clinical Study to Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel (of Cadila Healthcare Limited, India) Versus DUAC® Gel (of Stiefel Laboratories, USA) Versus Placebo (Vehicle Gel) in the Ratio of 2:2:1 Respectively, in Patients With Acne Vulgaris
Status: Enrolling
Updated:  1/31/2018
Universal BioPharma Research Inc.
mi
from
Dinuba, CA
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
A Randomized, Double-blind, Multicentric, Parallel-group, Active and Placebo Controlled, Three Arm Clinical Study to Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel (of Cadila Healthcare Limited, India) Versus DUAC® Gel (of Stiefel Laboratories, USA) Versus Placebo (Vehicle Gel) in the Ratio of 2:2:1 Respectively, in Patients With Acne Vulgaris
Status: Enrolling
Updated: 1/31/2018
Universal BioPharma Research Inc.
mi
from
Dinuba, CA
Click here to add this to my saved trials
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
A Randomized, Double-blind, Multicentric, Parallel-group, Active and Placebo Controlled, Three Arm Clinical Study to Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel (of Cadila Healthcare Limited, India) Versus DUAC® Gel (of Stiefel Laboratories, USA) Versus Placebo (Vehicle Gel) in the Ratio of 2:2:1 Respectively, in Patients With Acne Vulgaris
Status: Enrolling
Updated:  1/31/2018
Research Across America
mi
from
Santa Ana, CA
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
A Randomized, Double-blind, Multicentric, Parallel-group, Active and Placebo Controlled, Three Arm Clinical Study to Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel (of Cadila Healthcare Limited, India) Versus DUAC® Gel (of Stiefel Laboratories, USA) Versus Placebo (Vehicle Gel) in the Ratio of 2:2:1 Respectively, in Patients With Acne Vulgaris
Status: Enrolling
Updated: 1/31/2018
Research Across America
mi
from
Santa Ana, CA
Click here to add this to my saved trials
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
A Randomized, Double-blind, Multicentric, Parallel-group, Active and Placebo Controlled, Three Arm Clinical Study to Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel (of Cadila Healthcare Limited, India) Versus DUAC® Gel (of Stiefel Laboratories, USA) Versus Placebo (Vehicle Gel) in the Ratio of 2:2:1 Respectively, in Patients With Acne Vulgaris
Status: Enrolling
Updated:  1/31/2018
Visions Clinical Research
mi
from
Boynton Beach, FL
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
A Randomized, Double-blind, Multicentric, Parallel-group, Active and Placebo Controlled, Three Arm Clinical Study to Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel (of Cadila Healthcare Limited, India) Versus DUAC® Gel (of Stiefel Laboratories, USA) Versus Placebo (Vehicle Gel) in the Ratio of 2:2:1 Respectively, in Patients With Acne Vulgaris
Status: Enrolling
Updated: 1/31/2018
Visions Clinical Research
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
A Randomized, Double-blind, Multicentric, Parallel-group, Active and Placebo Controlled, Three Arm Clinical Study to Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel (of Cadila Healthcare Limited, India) Versus DUAC® Gel (of Stiefel Laboratories, USA) Versus Placebo (Vehicle Gel) in the Ratio of 2:2:1 Respectively, in Patients With Acne Vulgaris
Status: Enrolling
Updated:  1/31/2018
Dermatology Research Instititue
mi
from
Coral Gables, FL
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
A Randomized, Double-blind, Multicentric, Parallel-group, Active and Placebo Controlled, Three Arm Clinical Study to Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel (of Cadila Healthcare Limited, India) Versus DUAC® Gel (of Stiefel Laboratories, USA) Versus Placebo (Vehicle Gel) in the Ratio of 2:2:1 Respectively, in Patients With Acne Vulgaris
Status: Enrolling
Updated: 1/31/2018
Dermatology Research Instititue
mi
from
Coral Gables, FL
Click here to add this to my saved trials
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
A Randomized, Double-blind, Multicentric, Parallel-group, Active and Placebo Controlled, Three Arm Clinical Study to Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel (of Cadila Healthcare Limited, India) Versus DUAC® Gel (of Stiefel Laboratories, USA) Versus Placebo (Vehicle Gel) in the Ratio of 2:2:1 Respectively, in Patients With Acne Vulgaris
Status: Enrolling
Updated:  1/31/2018
International Dermatology Research, Inc.
mi
from
Miami, FL
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
A Randomized, Double-blind, Multicentric, Parallel-group, Active and Placebo Controlled, Three Arm Clinical Study to Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel (of Cadila Healthcare Limited, India) Versus DUAC® Gel (of Stiefel Laboratories, USA) Versus Placebo (Vehicle Gel) in the Ratio of 2:2:1 Respectively, in Patients With Acne Vulgaris
Status: Enrolling
Updated: 1/31/2018
International Dermatology Research, Inc.
mi
from
Miami, FL
Click here to add this to my saved trials
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
A Randomized, Double-blind, Multicentric, Parallel-group, Active and Placebo Controlled, Three Arm Clinical Study to Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel (of Cadila Healthcare Limited, India) Versus DUAC® Gel (of Stiefel Laboratories, USA) Versus Placebo (Vehicle Gel) in the Ratio of 2:2:1 Respectively, in Patients With Acne Vulgaris
Status: Enrolling
Updated:  1/31/2018
The Indiana Clinical Trials Center, PC
mi
from
Plainfield, IN
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
A Randomized, Double-blind, Multicentric, Parallel-group, Active and Placebo Controlled, Three Arm Clinical Study to Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel (of Cadila Healthcare Limited, India) Versus DUAC® Gel (of Stiefel Laboratories, USA) Versus Placebo (Vehicle Gel) in the Ratio of 2:2:1 Respectively, in Patients With Acne Vulgaris
Status: Enrolling
Updated: 1/31/2018
The Indiana Clinical Trials Center, PC
mi
from
Plainfield, IN
Click here to add this to my saved trials
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
A Randomized, Double-blind, Multicentric, Parallel-group, Active and Placebo Controlled, Three Arm Clinical Study to Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel (of Cadila Healthcare Limited, India) Versus DUAC® Gel (of Stiefel Laboratories, USA) Versus Placebo (Vehicle Gel) in the Ratio of 2:2:1 Respectively, in Patients With Acne Vulgaris
Status: Enrolling
Updated:  1/31/2018
Dermatology Specialists
mi
from
Louisville, KY
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
A Randomized, Double-blind, Multicentric, Parallel-group, Active and Placebo Controlled, Three Arm Clinical Study to Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel (of Cadila Healthcare Limited, India) Versus DUAC® Gel (of Stiefel Laboratories, USA) Versus Placebo (Vehicle Gel) in the Ratio of 2:2:1 Respectively, in Patients With Acne Vulgaris
Status: Enrolling
Updated: 1/31/2018
Dermatology Specialists
mi
from
Louisville, KY
Click here to add this to my saved trials
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
A Randomized, Double-blind, Multicentric, Parallel-group, Active and Placebo Controlled, Three Arm Clinical Study to Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel (of Cadila Healthcare Limited, India) Versus DUAC® Gel (of Stiefel Laboratories, USA) Versus Placebo (Vehicle Gel) in the Ratio of 2:2:1 Respectively, in Patients With Acne Vulgaris
Status: Enrolling
Updated:  1/31/2018
Minnesota Clinical Study Center
mi
from
Fridley, MN
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
A Randomized, Double-blind, Multicentric, Parallel-group, Active and Placebo Controlled, Three Arm Clinical Study to Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel (of Cadila Healthcare Limited, India) Versus DUAC® Gel (of Stiefel Laboratories, USA) Versus Placebo (Vehicle Gel) in the Ratio of 2:2:1 Respectively, in Patients With Acne Vulgaris
Status: Enrolling
Updated: 1/31/2018
Minnesota Clinical Study Center
mi
from
Fridley, MN
Click here to add this to my saved trials
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
A Randomized, Double-blind, Multicentric, Parallel-group, Active and Placebo Controlled, Three Arm Clinical Study to Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel (of Cadila Healthcare Limited, India) Versus DUAC® Gel (of Stiefel Laboratories, USA) Versus Placebo (Vehicle Gel) in the Ratio of 2:2:1 Respectively, in Patients With Acne Vulgaris
Status: Enrolling
Updated:  1/31/2018
Skin Specialists, PC
mi
from
Omaha, NE
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
A Randomized, Double-blind, Multicentric, Parallel-group, Active and Placebo Controlled, Three Arm Clinical Study to Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel (of Cadila Healthcare Limited, India) Versus DUAC® Gel (of Stiefel Laboratories, USA) Versus Placebo (Vehicle Gel) in the Ratio of 2:2:1 Respectively, in Patients With Acne Vulgaris
Status: Enrolling
Updated: 1/31/2018
Skin Specialists, PC
mi
from
Omaha, NE
Click here to add this to my saved trials
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
A Randomized, Double-blind, Multicentric, Parallel-group, Active and Placebo Controlled, Three Arm Clinical Study to Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel (of Cadila Healthcare Limited, India) Versus DUAC® Gel (of Stiefel Laboratories, USA) Versus Placebo (Vehicle Gel) in the Ratio of 2:2:1 Respectively, in Patients With Acne Vulgaris
Status: Enrolling
Updated:  1/31/2018
Academic Dermatology Associates
mi
from
Albuquerque, NM
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
A Randomized, Double-blind, Multicentric, Parallel-group, Active and Placebo Controlled, Three Arm Clinical Study to Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel (of Cadila Healthcare Limited, India) Versus DUAC® Gel (of Stiefel Laboratories, USA) Versus Placebo (Vehicle Gel) in the Ratio of 2:2:1 Respectively, in Patients With Acne Vulgaris
Status: Enrolling
Updated: 1/31/2018
Academic Dermatology Associates
mi
from
Albuquerque, NM
Click here to add this to my saved trials
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
A Randomized, Double-blind, Multicentric, Parallel-group, Active and Placebo Controlled, Three Arm Clinical Study to Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel (of Cadila Healthcare Limited, India) Versus DUAC® Gel (of Stiefel Laboratories, USA) Versus Placebo (Vehicle Gel) in the Ratio of 2:2:1 Respectively, in Patients With Acne Vulgaris
Status: Enrolling
Updated:  1/31/2018
Yardley Dermatology Associates
mi
from
Yardley, PA
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
A Randomized, Double-blind, Multicentric, Parallel-group, Active and Placebo Controlled, Three Arm Clinical Study to Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel (of Cadila Healthcare Limited, India) Versus DUAC® Gel (of Stiefel Laboratories, USA) Versus Placebo (Vehicle Gel) in the Ratio of 2:2:1 Respectively, in Patients With Acne Vulgaris
Status: Enrolling
Updated: 1/31/2018
Yardley Dermatology Associates
mi
from
Yardley, PA
Click here to add this to my saved trials
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
A Randomized, Double-blind, Multicentric, Parallel-group, Active and Placebo Controlled, Three Arm Clinical Study to Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel (of Cadila Healthcare Limited, India) Versus DUAC® Gel (of Stiefel Laboratories, USA) Versus Placebo (Vehicle Gel) in the Ratio of 2:2:1 Respectively, in Patients With Acne Vulgaris
Status: Enrolling
Updated:  1/31/2018
Discover Research
mi
from
Bryan, TX
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
A Randomized, Double-blind, Multicentric, Parallel-group, Active and Placebo Controlled, Three Arm Clinical Study to Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel (of Cadila Healthcare Limited, India) Versus DUAC® Gel (of Stiefel Laboratories, USA) Versus Placebo (Vehicle Gel) in the Ratio of 2:2:1 Respectively, in Patients With Acne Vulgaris
Status: Enrolling
Updated: 1/31/2018
Discover Research
mi
from
Bryan, TX
Click here to add this to my saved trials
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
A Randomized, Double-blind, Multicentric, Parallel-group, Active and Placebo Controlled, Three Arm Clinical Study to Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel (of Cadila Healthcare Limited, India) Versus DUAC® Gel (of Stiefel Laboratories, USA) Versus Placebo (Vehicle Gel) in the Ratio of 2:2:1 Respectively, in Patients With Acne Vulgaris
Status: Enrolling
Updated:  1/31/2018
Osmania General Hospital
mi
from
Hyderabad,
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
A Randomized, Double-blind, Multicentric, Parallel-group, Active and Placebo Controlled, Three Arm Clinical Study to Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel (of Cadila Healthcare Limited, India) Versus DUAC® Gel (of Stiefel Laboratories, USA) Versus Placebo (Vehicle Gel) in the Ratio of 2:2:1 Respectively, in Patients With Acne Vulgaris
Status: Enrolling
Updated: 1/31/2018
Osmania General Hospital
mi
from
Hyderabad,
Click here to add this to my saved trials
Comparison of Two Salicylic Acid Formulations
A Split-Face, Paired-Comparison, Pilot Study to Evaluate Safety and Efficacy of Two Topical Salicylic Acid 1.0% Creams for Mild to Moderate Acne Vulgaris
Status: Enrolling
Updated:  1/31/2018
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Comparison of Two Salicylic Acid Formulations
A Split-Face, Paired-Comparison, Pilot Study to Evaluate Safety and Efficacy of Two Topical Salicylic Acid 1.0% Creams for Mild to Moderate Acne Vulgaris
Status: Enrolling
Updated: 1/31/2018
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
A Single-Center 2-Arm Study for Lentigines on the Hands
A Single-Center 2-Arm Study of the Enlighten and Excel V Laser for Lentigines on the Hands
Status: Enrolling
Updated:  2/1/2018
DuPage Medical Group
mi
from
Naperville, IL
A Single-Center 2-Arm Study for Lentigines on the Hands
A Single-Center 2-Arm Study of the Enlighten and Excel V Laser for Lentigines on the Hands
Status: Enrolling
Updated: 2/1/2018
DuPage Medical Group
mi
from
Naperville, IL
Click here to add this to my saved trials
CeraVe Cream Compared to Desitin Paste for Treating Diaper Dermatitis in Infants
Randomized, Double-Blind, Parallel Group, Non-Inferiority Clinical Trial of CeraVe Baby Diaper Rash Cream Compared to Desitin Maximum Strength Original Paste for Management of Diaper Dermatitis in Infants
Status: Enrolling
Updated:  2/13/2018
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
CeraVe Cream Compared to Desitin Paste for Treating Diaper Dermatitis in Infants
Randomized, Double-Blind, Parallel Group, Non-Inferiority Clinical Trial of CeraVe Baby Diaper Rash Cream Compared to Desitin Maximum Strength Original Paste for Management of Diaper Dermatitis in Infants
Status: Enrolling
Updated: 2/13/2018
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
CeraVe Cream Compared to Desitin Paste for Treating Diaper Dermatitis in Infants
Randomized, Double-Blind, Parallel Group, Non-Inferiority Clinical Trial of CeraVe Baby Diaper Rash Cream Compared to Desitin Maximum Strength Original Paste for Management of Diaper Dermatitis in Infants
Status: Enrolling
Updated:  2/13/2018
Northwestern University Department of Dermatology
mi
from
Chicago, IL
CeraVe Cream Compared to Desitin Paste for Treating Diaper Dermatitis in Infants
Randomized, Double-Blind, Parallel Group, Non-Inferiority Clinical Trial of CeraVe Baby Diaper Rash Cream Compared to Desitin Maximum Strength Original Paste for Management of Diaper Dermatitis in Infants
Status: Enrolling
Updated: 2/13/2018
Northwestern University Department of Dermatology
mi
from
Chicago, IL
Click here to add this to my saved trials
CeraVe Cream Compared to Desitin Paste for Treating Diaper Dermatitis in Infants
Randomized, Double-Blind, Parallel Group, Non-Inferiority Clinical Trial of CeraVe Baby Diaper Rash Cream Compared to Desitin Maximum Strength Original Paste for Management of Diaper Dermatitis in Infants
Status: Enrolling
Updated:  2/13/2018
Lurie Children's Hospital Outpatient Clinic at Lincoln Park
mi
from
Chicago, IL
CeraVe Cream Compared to Desitin Paste for Treating Diaper Dermatitis in Infants
Randomized, Double-Blind, Parallel Group, Non-Inferiority Clinical Trial of CeraVe Baby Diaper Rash Cream Compared to Desitin Maximum Strength Original Paste for Management of Diaper Dermatitis in Infants
Status: Enrolling
Updated: 2/13/2018
Lurie Children's Hospital Outpatient Clinic at Lincoln Park
mi
from
Chicago, IL
Click here to add this to my saved trials
Alopecia Areata Registry
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated:  2/15/2018
University of California at San Francisco
mi
from
San Francisco, CA
Alopecia Areata Registry
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated: 2/15/2018
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Alopecia Areata Registry
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated:  2/15/2018
University of Colorado - UCHSC - Health Science Center at Fitzsimons
mi
from
Aurora, CO
Alopecia Areata Registry
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated: 2/15/2018
University of Colorado - UCHSC - Health Science Center at Fitzsimons
mi
from
Aurora, CO
Click here to add this to my saved trials
Alopecia Areata Registry
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated:  2/15/2018
Univ of Minnesota
mi
from
Minneapolis, MN
Alopecia Areata Registry
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated: 2/15/2018
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Alopecia Areata Registry
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated:  2/15/2018
Columbia University
mi
from
New York, NY
Alopecia Areata Registry
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated: 2/15/2018
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Alopecia Areata Registry
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated:  2/15/2018
M.D. Anderson Cancer Center
mi
from
Houston, TX
Alopecia Areata Registry
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated: 2/15/2018
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Pilot Study of Ustekinumab for Subjects With Chronic Atopic Dermatitis
Randomized Pilot Study of Ustekinumab for Subjects With Chronic Atopic Dermatitis Who Have Sub-optimal Response to Prior Therapy
Status: Enrolling
Updated:  2/15/2018
Rockefeller University
mi
from
New York, NY
Pilot Study of Ustekinumab for Subjects With Chronic Atopic Dermatitis
Randomized Pilot Study of Ustekinumab for Subjects With Chronic Atopic Dermatitis Who Have Sub-optimal Response to Prior Therapy
Status: Enrolling
Updated: 2/15/2018
Rockefeller University
mi
from
New York, NY
Click here to add this to my saved trials
Behavioral Self-Help Intervention for Pediatric Atopic Dermatitis and Eczema Patients
Behavioral Self-Help Intervention for Pediatric Atopic Dermatitis and Eczema Patients
Status: Enrolling
Updated:  2/15/2018
Pavilion Dermatology Suite K
mi
from
Jackson, MS
Behavioral Self-Help Intervention for Pediatric Atopic Dermatitis and Eczema Patients
Behavioral Self-Help Intervention for Pediatric Atopic Dermatitis and Eczema Patients
Status: Enrolling
Updated: 2/15/2018
Pavilion Dermatology Suite K
mi
from
Jackson, MS
Click here to add this to my saved trials
A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Baricitinib in Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated:  2/16/2018
Forward Clinical Trials
mi
from
Tampa, FL
A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Baricitinib in Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 2/16/2018
Forward Clinical Trials
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Baricitinib in Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated:  2/16/2018
Northwestern University
mi
from
Chicago, IL
A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Baricitinib in Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 2/16/2018
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Baricitinib in Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated:  2/16/2018
Icahn School of Medicine
mi
from
New York, NY
A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Baricitinib in Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 2/16/2018
Icahn School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Baricitinib in Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated:  2/16/2018
Menter Dermatology Research Institute
mi
from
Dallas, TX
A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Baricitinib in Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 2/16/2018
Menter Dermatology Research Institute
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Baricitinib in Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated:  2/16/2018
Center for Clinical Studies
mi
from
Houston, TX
A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Baricitinib in Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 2/16/2018
Center for Clinical Studies
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Baricitinib in Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated:  2/16/2018
Center for Clinical Studies
mi
from
Houston, TX
A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Baricitinib in Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 2/16/2018
Center for Clinical Studies
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Baricitinib in Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated:  2/16/2018
Center for Clinical Studies
mi
from
Webster, TX
A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Baricitinib in Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 2/16/2018
Center for Clinical Studies
mi
from
Webster, TX
Click here to add this to my saved trials
A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Baricitinib in Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated:  2/16/2018
Oregon Health and Science University
mi
from
Portland, OR
A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Baricitinib in Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 2/16/2018
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Baricitinib in Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated:  2/16/2018
Dermatology Research Associates
mi
from
Los Angeles, CA
A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Baricitinib in Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 2/16/2018
Dermatology Research Associates
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Baricitinib in Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated:  2/16/2018
Medical Dermatology Specialists
mi
from
Atlanta, GA
A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Baricitinib in Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 2/16/2018
Medical Dermatology Specialists
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Baricitinib in Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated:  2/16/2018
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Fukuoka-shi,
A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Baricitinib in Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 2/16/2018
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Fukuoka-shi,
Click here to add this to my saved trials
Response of Urticaria to Stress Intervention
Effect of Psychological Stress Intervention on Chronic Urticaria Activity and Immune Dysregulation
Status: Enrolling
Updated:  2/16/2018
University of Mississippi Medical Center
mi
from
Jackson, MS
Response of Urticaria to Stress Intervention
Effect of Psychological Stress Intervention on Chronic Urticaria Activity and Immune Dysregulation
Status: Enrolling
Updated: 2/16/2018
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
Response of Urticaria to Stress Intervention
Effect of Psychological Stress Intervention on Chronic Urticaria Activity and Immune Dysregulation
Status: Enrolling
Updated:  2/16/2018
University of Mississippi
mi
from
Jackson, MS
Response of Urticaria to Stress Intervention
Effect of Psychological Stress Intervention on Chronic Urticaria Activity and Immune Dysregulation
Status: Enrolling
Updated: 2/16/2018
University of Mississippi
mi
from
Jackson, MS
Click here to add this to my saved trials
Ultherapy® for Treating the Face and Neck Using Standard Versus Simulines Transducers
Evaluation of the Ulthera® System for Lifting and Tightening the Face and Neck Using Standard Transducers Versus Simulines Transducers
Status: Enrolling
Updated:  2/20/2018
Clinical Testing of Beverly Hills
mi
from
Beverly Hills, CA
Ultherapy® for Treating the Face and Neck Using Standard Versus Simulines Transducers
Evaluation of the Ulthera® System for Lifting and Tightening the Face and Neck Using Standard Transducers Versus Simulines Transducers
Status: Enrolling
Updated: 2/20/2018
Clinical Testing of Beverly Hills
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Ultherapy® for Treating the Face and Neck Using Standard Versus Simulines Transducers
Evaluation of the Ulthera® System for Lifting and Tightening the Face and Neck Using Standard Transducers Versus Simulines Transducers
Status: Enrolling
Updated:  2/20/2018
California Skin Institute - Saratoga
mi
from
Saratoga, CA
Ultherapy® for Treating the Face and Neck Using Standard Versus Simulines Transducers
Evaluation of the Ulthera® System for Lifting and Tightening the Face and Neck Using Standard Transducers Versus Simulines Transducers
Status: Enrolling
Updated: 2/20/2018
California Skin Institute - Saratoga
mi
from
Saratoga, CA
Click here to add this to my saved trials